Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis
ACR Open Rheumatology · 2026-04 · 8 (4)
DOI: 10.1002/acr2.90033 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACR Open Rheumatology, online erschienen am 19.04.2026. Verfasst von Alannah Quinlivan und 13 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne, Royal Australasian College of Physicians, National Health and Medical Research Council.
Abstract (Originalsprache)
Objective
Gastroesophageal reflux disease (GERD) affects up to 90% of patients with systemic sclerosis (SSc). Chronic esophageal acid exposure can result in complications including the formation of esophageal strictures (ES). Proton pump inhibitors can alter gastric acid pH and improve GORD symptoms; however, there have been no recent studies evaluating the prevalence of SSc–ES since these medications became widely available. Our aim was to investigate the prevalence of SSc–ES over time and identify risk factors associated with ES.
Methods
Consecutive patients from the Australian Scleroderma Cohort Study who met American College of Rheumatology/EULAR criteria for SSc were included. Clinically significant ES was defined as characteristic findings seen on gastroscopy or patient‐reported ES requiring dilatation. Multivariable logistic regression analysis was used to identify factors associated with SSc–ES. The time to SSc–ES development from SSc disease onset was evaluated using Kaplan‐Meier survival analysis.
Results
ES affected 191 of 1,543 patients (12.4%) and were associated with a longer disease duration, gastric antral vascular ectasia, esophageal dysmotility, reflux esophagitis, and myocardial disease on multivariable logistic regression analysis ( P < 0.05). Compared to patients with SSc diagnosed before 1990, those who were diagnosed between 2000 and 2010 and 2010 and 2023 were significantly less likely to have clinically significant ES on multivariable logistic regression analysis (odds ratio 0.45 and 0.42, respectively; P = 0.002).The median disease duration at time of SSc–ES diagnosis increased from 3 (interquartile range 0–5) years to 11.5 (interquartile range 3.5–24) years for those diagnosed with SSc–ES before 1990 to those diagnosed after 2010 ( P = 0.0027).
Conclusion
SSc–ES is associated with a longer disease duration and other gastrointestinal SSc manifestations, with prevalence decreasing over time.
Förderung
- University of Melbourne
- Royal Australasian College of Physicians
- National Health and Medical Research Council
- Scleroderma Victoria
- Arthritis Australia
- Boehringer Ingelheim
- Janssen Research and Development
Zitieren
APA
Quinlivan, A., Hansen, D., Stevens, W., Ferdowsi, N., Proudman, S., Walker, J., Sahhar, J., Ngian, G., Apostolopoulos, D., Host, L. V., Basnayake, C., Morrisroe, K., Ross, L., & Nikpour, M. (2026). Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis. ACR Open Rheumatology, 8(4). https://doi.org/10.1002/acr2.90033
Vancouver
Quinlivan A, Hansen D, Stevens W, Ferdowsi N, Proudman S, Walker J, et al. Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis. ACR Open Rheumatology. 2026;8(4). doi:10.1002/acr2.90033
BibTeX
@article{Quinlivan2026,
author = {Quinlivan, Alannah and Hansen, Dylan and Stevens, Wendy and Ferdowsi, Nava and Proudman, Susanna and Walker, Jennifer and Sahhar, Joanne and Ngian, Gene‐Siew and Apostolopoulos, Diane and Host, Lauren V. and Basnayake, Chamara and Morrisroe, Kathleen and Ross, Laura and Nikpour, Mandana},
title = {Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis},
journal = {ACR Open Rheumatology},
year = {2026},
volume = {8},
number = {4},
doi = {10.1002/acr2.90033}
}
EUVIMED